India's Ranbaxy Gets Court Ruling Against Mylan Try To Block Generic
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories of India won a victory in a U.S. court, which dismissed a suit by Mylan Laboratories to block Ranbaxy's right to market a generic of a key drug